The ISPOR Nominations Committee has selected the following candidates as nominees for the ISPOR Board for consideration by the membership.
There are 2 candidates for President-elect. The President-Elect retains a seat on the Board for 3 years, first as President-Elect for 1 year, then as President for 1 year, and finally as Immediate Past President for 1 year. All terms commence on July 1, 2025.
In 2017, the ISPOR bylaws were changed to extend the terms for Directors from 2 to 3 years. This change will result in no Director vacancies every third year. Hence, there are no openings for Directors to begin in 2025, but there will be 3 Director vacancies in 2026.
President-Elect
Beth Devine, PhD, PharmD, MBA
Professor Emeritus, The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, School of Pharmacy, University of Washington, Seattle, WA, USA
Darius Lakdawalla, PhD
Quintiles Professor of Pharmaceutical Development and Regulatory Innovation
USC Leonard D. Schaeffer Center for Health Policy and Economics, School of Pharmacy University of Southern California, Los Angeles, CA, USA
Thank you in advance for casting your vote before April 1, 2025. As a member you must log-in to your profile to access the ballot.
Forgot your password? Click here
Please contact membership@ispor.org for login issues.
Please contact governance@ispor.org with questions related to the elections.
ISPOR’s Campaigning Policy for candidates and members is at ISPOR Campaigning Policies 2022 (PDF).